Posts Tagged ‘Pfizer’
Pfizer beats Q4 profit estimates on strong drug demand
Robust demand for its heart and oncology drugs helped achieve total sales for the quarter of US$17.56 billion Published Tue, Feb 3, 2026 · 09:21 PM [WASHINGTON] Pfizer on Tuesday (Feb 3) reported fourth-quarter profit above Wall Street estimates, as sustained demand for older drugs such as blood thinner Eliquis helped offset fading sales of…
Read MorePfizer forecasts 2026 profit below expectations on lower Covid product sales
Pfizer has rolled out a sweeping cost reduction programme in response to the drop in Covid-19 sales [WASHINGTON] Pfizer on Tuesday (Dec 16) forecast 2026 profit below Wall Street estimates as it expects a steep drop in sales of its Covid products and a revenue hit from the loss of exclusivity on some drugs. Investors…
Read MoreEli Lilly, Pfizer Among 19 Drugs Approved for China’s Commercial Health Insurance
China has approved 19 innovative medicines — including major treatments from Eli Lilly, Pfizer, and Johnson & Johnson — for its first commercial health insurance drug catalog, creating a new pathway for companies to sell advanced therapies at better prices. The announcement was made Sunday in Guangzhou, marking a major shift in how China plans…
Read MorePfizer looks to sell stake in pandemic vaccine partner BioNTech
[NEW YORK] Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the pandemic’s most lucrative collaborations. The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between US$108 to US$111.70 per share, according to people familiar with the…
Read MorePfizer, Novo Nordisk Locked in High-Stakes Fight Over Obesity Drug Innovator Metsera
Pfizer and Novo Nordisk are locked in a high-stakes battle to acquire US obesity drug developer Metsera, sending shockwaves through the pharmaceutical industry. The two giants have submitted competing bids, with Metsera calling Novo’s $10 billion offer “superior.” The bidding war began last week when Novo Nordisk unexpectedly launched a bid for Metsera, despite the…
Read MorePfizer boosts profit view as it battles for obesity startup
[NEW YORK] Pfizer raised its 2025 profit forecast for the second time this year, as ongoing cost cuts helped make up for slow sales growth that’s driving its battle for the obesity start up Metsera. The drugmaker’s adjusted earnings for the year will be US$3 a share to US$3.15 a share, Pfizer said on Tuesday…
Read MorePfizer Sues Rivals Metsera, Novo Nordisk Over Alleged Interference in Merger Talks
Pfizer Inc. has filed a lawsuit against Metsera Inc. and Danish drugmaker Novo Nordisk A/S, aiming to block Novo’s bid for the obesity treatment startup. The legal move comes as a fast-developing battle over Metsera, which is developing potential oral and injectable treatments for obesity and diabetes. According to Bloomberg, Pfizer told the Delaware Court…
Read MorePfizer sues Metsera, Novo Nordisk over rival obesity drug bid
[BENGALURU] Pfizer on Friday (Oct 31) filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker’s US$8.5 billion bid for the US obesity drug developer to be a superior offer. Pfizer asked the Delaware court to issue a temporary restraining order to block Metsera from…
Read MorePfizer Sued by 1,000 Women Over Birth Control Brain Tumour Risk
More than 1,000 women across the United States have filed lawsuits against pharmaceutical giant Pfizer, alleging that its popular contraceptive injection, Depo-Provera, caused them to develop brain tumours. The legal action follows the publication of new research linking prolonged use of the birth control drug to an increased risk of meningioma, a tumour that forms…
Read MoreTrump Secures Major Win as AstraZeneca Joins Pfizer in Lowering US Drug Prices
President Donald Trump secured a major victory Friday as AstraZeneca agreed to lower its prescription drug prices for Medicaid—a move that follows a similar deal made by Pfizer and marks a center point in the administration’s push for more affordable medicine. According to AP, the agreement, made public during a White House Oval Office event,…
Read More